Search Results

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study.

• Authors : Puspitasari, Metalia¹ (AUTHOR) ; Sattwika, Prenali D.^1,2,3 (AUTHOR); Rahari, Dzerlina S.² (AUTHOR)

• Source: Scientific Reports. 7/18/2023, Issue 1, p1-11. 11p.

Record details

Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery.

• Authors : van Rijn, Cees J. M.¹ (AUTHOR); Vlaming, Killian E.^2,3 (AUTHOR); Bem, Reinout A.⁴ (AUTHOR)

• Source: Scientific Reports. 6/27/2023, Vol. 13 Issue 1, p1-9. 9p.

Record details

Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study.

• Authors : Prather, Aric A.^1,2 (AUTHOR) ; Dutcher, Ethan G.^1,2 (AUTHOR); Robinson, James³ (AUTHOR)

• Source: Scientific Reports. 5/9/2023, Vol. 13 Issue 1, p1-9. 9p.

Record details

Forecasting sub-national trends in COVID-19 vaccine uptake in the UK before vaccine rollout.

• Authors : de Figueiredo, A.^1,2 (AUTHOR)

• Source: Scientific Reports. 12/13/2022, Vol. 12 Issue 1, p1-12. 12p.

Record details

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals.

• Authors : Cavic, Milena¹ (AUTHOR) ; Nesic, Andrijana² (AUTHOR); Mirjacic Martinovic, Katarina¹ (AUTHOR)

• Source: Scientific Reports. 4/17/2023, Vol. 13 Issue 1, p1-8. 8p.

Record details

Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.

• Authors : Galli, Margherita^1,2 (AUTHOR); Zardini, Agnese¹ (AUTHOR); Gamshie, Worku Nigussa³ (AUTHOR)

• Source: Scientific Reports. 4/5/2023, Vol. 13 Issue 1, p1-12. 12p.

Record details

Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave.

• Authors : Sun, Christopher L. F.^1,2 (AUTHOR); Jaffe, Eli^3,4 (AUTHOR); Levi, Retsef¹ (AUTHOR)

• Source: Scientific Reports. 5/6/2022, Vol. 12 Issue 1, p1-12. 12p.

Record details

Risk factor targeting for vaccine prioritization during the COVID-19 pandemic.

• Authors : Chapman, Lloyd A. C.^1,2 (AUTHOR) ; Shukla, Poojan¹ (AUTHOR); Rodríguez-Barraquer, Isabel^1,3 (AUTHOR)

• Source: Scientific Reports. 2/23/2022, Vol. 12 Issue 1, p1-12. 12p.

Record details

Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose.

• Authors : Berec, Luděk^1,2 (AUTHOR) ; Levínský, René³ (AUTHOR); Weiner, Jakub⁴ (AUTHOR)

• Source: Scientific Reports. 5/10/2022, Vol. 12 Issue 1, p1-12. 12p.

Record details

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike.

• Authors : van der Velden, Yme U.¹ (AUTHOR); Grobben, Marloes¹ (AUTHOR); Caniels, Tom G.¹ (AUTHOR)

• Source: Scientific Reports. 3/10/2022, Vol. 12 Issue 1, p1-7. 7p.

Record details

The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates.

• Authors : Al Kaabi, Nawal¹ (AUTHOR); Oulhaj, Abderrahim^2,3 (AUTHOR); Al Hosani, Farida Ismail⁴ (AUTHOR)

• Source: Scientific Reports. 1/11/2022, Vol. 12 Issue 1, p1-8. 8p.

Record details

Informing selection of drugs for COVID-19 treatment through adverse events analysis.

• Authors : Guo, Wenjing¹; Pan, Bohu¹; Sakkiah, Sugunadevi¹

• Source: Scientific Reports. 7/7/2021, Vol. 11 Issue 1, p1-7. 7p.

Record details

Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19.

• Authors : Grauer, Jens¹; Löwen, Hartmut¹; Liebchen, Benno²

• Source: Scientific Reports. 12/9/2020, Vol. 10 Issue 1, p1-10. 10p.

Record details

Phylogenomic analysis uncovers a 9-year variation of Uganda influenza type-A strains from the WHO-recommended vaccines and other Africa strains.

• Authors : Nabakooza, Grace^1,2,3,4 (AUTHOR) ; Owuor, D. Collins⁵ (AUTHOR); de Laurent, Zaydah R.⁵ (AUTHOR)

Subjects: *COVID-19; *EXTRACELLULAR matrix proteins; *VACCINESUGANDA; AFRICA

• Source: Scientific Reports. 4/4/2023, Vol. 13 Issue 1, p1-11. 11p.

Record details

Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model.

• Authors : Abdoli, Asghar; Jamshidi, Hamidreza; Taqavian, Mohammad

Subjects: SARS-CoV-2 Omicron variant; BOOSTER vaccines; IMMUNOGLOBULINSWUHAN (China)

• Source: Scientific Reports; 1/5/2024, Vol. 14 Issue 1, p1-8, 8p

Record details

Optimal spatial evaluation of a pro rata vaccine distribution rule for COVID-19.

• Authors : Castonguay, François M.¹ (AUTHOR) ; Blackwood, Julie C.² (AUTHOR); Howerton, Emily³ (AUTHOR)

• Source: Scientific Reports. Dec2023, Vol. 13 Issue 1, p1-14. 14p.

Record details

Model-informed health and socio-economic benefits of enhancing global equity and access to Covid-19 vaccines.

• Authors : Italia M; Department of Electronic, Information, and Bioengineering, Politecnico di Milano, Milan, Italy. .; Della Rossa F

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Dec 07; Vol. 13 (1), pp. 21707. Date of Electronic Publication: 2023 Dec 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.

• Authors : Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857, Singapore.; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117547, Singapore.

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Nov 20; Vol. 13 (1), pp. 20263. Date of Electronic Publication: 2023 Nov 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Investigating the effects of vaccine on COVID-19 disease propagation using a Bayesian approach.

• Authors : Ling L; Lyles School of Civil Engineering, Purdue University, West Lafayette city, 47906, USA.; Ukkusuri SV

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

• Source: Scientific reports [Sci Rep] 2023 Aug 17; Vol. 13 (1), pp. 13374. Date of Electronic Publication: 2023 Aug 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.

• Authors : Kulkarni PS; Gunale B ...

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

• Source: Scientific reports [Sci Rep] 2023 Oct 03; Vol. 13 (1), pp. 16579. Date of Electronic Publication: 2023 Oct 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Evaluating COVID-19 control measures in mass gathering events with vaccine inequalities.

• Authors : Al-Shaery, Ali M.¹ (AUTHOR); Hejase, Bilal² (AUTHOR); Tridane, Abdessamad³ (AUTHOR)

• Source: Scientific Reports. 3/7/2022, Vol. 12 Issue 1, p1-9. 9p.

Record details

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023.

• Authors : Puenpa J; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Chansaenroj J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/genetics ; Vaccines*SARS-CoV-2 variants

• Source: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 645. Date of Electronic Publication: 2024 Jan 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.

• Authors : Nash D; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA. .; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 644. Date of Electronic Publication: 2024 Jan 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia.

• Authors : Uusküla A; Department of Family Medicine and Public Health, University of Tartu, 50411, Tartu, Estonia. .; Pisarev H

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Nov 21; Vol. 13 (1), pp. 20347. Date of Electronic Publication: 2023 Nov 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

The quantification of vaccine uptake in the Nordic countries and impact on key indicators of COVID-19 severity and healthcare stress level via age range comparative analysis.

• Authors : Islind, Anna Sigridur¹ (AUTHOR); Óskarsdóttir, María¹ (AUTHOR) ; Cot, Corentin^2,3 (AUTHOR)

• Source: Scientific Reports. 10/7/2022, Vol. 12 Issue 1, p1-16. 16p.

Record details

Public support for more stringent vaccine policies increases with vaccine effectiveness.

• Authors : Koenig R; Department of Political Economy, King's College London, London, WC2R 2LS, UK.; Savani MM

Subjects: COVID-19 Vaccines* ; Vaccines*; Humans

• Source: Scientific reports [Sci Rep] 2024 Jan 19; Vol. 14 (1), pp. 1748. Date of Electronic Publication: 2024 Jan 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Promote to protect: data-driven computational model of peer influence for vaccine perception.

• Authors : Ghosh S; Department of Physics, NIT Durgapur, Durgapur, India. .; Bhattacharya S

Subjects: COVID-19 Vaccines* ; Vaccines*; Humans

• Source: Scientific reports [Sci Rep] 2024 Jan 03; Vol. 14 (1), pp. 306. Date of Electronic Publication: 2024 Jan 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.

• Authors : Gu Y; SCOPE Cohort Study Group

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans SARS-CoV-2 variants

• Source: Scientific reports [Sci Rep] 2023 Dec 09; Vol. 13 (1), pp. 21810. Date of Electronic Publication: 2023 Dec 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Despite misinformation, low trust, and conflict in Somalia, high demand for vaccines and a negative endorsement effect of non-state authorities.

• Authors : Aarslew LF; Department of Political Science, Aarhus University, Aarhus, Denmark. .; Haas N

Subjects: COVID-19 Vaccines* ; Vaccines*; Humans

• Source: Scientific reports [Sci Rep] 2023 Dec 07; Vol. 13 (1), pp. 21689. Date of Electronic Publication: 2023 Dec 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II.

• Authors : Szilágyi D; Hungarian Angioedema Center of Reference and Excellence, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.; Horváth HR

Subjects: Hereditary Angioedema Types I and II*/Hereditary Angioedema Types I and II*/Hereditary Angioedema Types I and II*/drug therapy ; Hereditary Angioedema Types I and II*/Hereditary Angioedema Types I and II*/Hereditary Angioedema Types I and II*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

• Source: Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20446. Date of Electronic Publication: 2023 Nov 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease.

• Authors : Yap DY; Division of Nephrology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.; Fong CH

Subjects: COVID-19* ; Renal Insufficiency, Chronic* ; Vaccines*SARS-CoV-2 variants

• Source: Scientific reports [Sci Rep] 2023 Nov 15; Vol. 13 (1), pp. 19932. Date of Electronic Publication: 2023 Nov 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1.

• Authors : Alrubayyi A; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Division of Infection and Immunity, Institute for Immunity and Transplantation, University College London, London, UK.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; HIV-1* ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Nov 03; Vol. 13 (1), pp. 18994. Date of Electronic Publication: 2023 Nov 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.

• Authors : Tabynov K; International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan.; Preclinical Research Laboratory with Vivarium, M. Aikimbayev National Research Center for Especially Dangerous Infections, Almaty, Kazakhstan.

Subjects: Chitosan* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Jul 26; Vol. 13 (1), pp. 12115. Date of Electronic Publication: 2023 Jul 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

A deep learning predictive model for public health concerns and hesitancy toward the COVID-19 vaccines.

• Authors : Farghaly HM; Computer Science Department, Faculty of Science, Minia University, Minya, Egypt.; Scientific Research Group in Egypt (SRGE).

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Deep Learning* ; Drug-Related Side Effects and Adverse Reactions*

• Source: Scientific reports [Sci Rep] 2023 Jun 06; Vol. 13 (1), pp. 9171. Date of Electronic Publication: 2023 Jun 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Evaluating COVID-19 vaccination intentions and vaccine hesitancy among parents of children with autism spectrum disorder.

• Authors : Khoodoruth MAS; Child and Adolescent Mental Health Service, Hamad Medical Corporation, PO Box 3050, Doha, Qatar. .; Division of Genomics and Precision Medicine, College of Health and Life Sciences, Hamad Bin Khalifa University, Education City, Qatar. .

Subjects: Autism Spectrum Disorder* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 May 05; Vol. 13 (1), pp. 7353. Date of Electronic Publication: 2023 May 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

The COVID-19 vaccination decision-making preferences of elderly people: a discrete choice experiment.

• Authors : Chen Y; School of Public Administration and Policy, Renmin University of China, Beijing, 100872, China.; Wang J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2023 Mar 31; Vol. 13 (1), pp. 5242. Date of Electronic Publication: 2023 Mar 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Exploring the vaccine-induced immunity against severe acute respiratory syndrome coronavirus 2 in healthcare workers.

• Authors : Lim YK; Department of Laboratory Medicine, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, South Korea.; Kweon OJ

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

• Source: Scientific reports [Sci Rep] 2023 Apr 26; Vol. 13 (1), pp. 6830. Date of Electronic Publication: 2023 Apr 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.

• Authors : Yung CF; Infectious Disease Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. .; Duke-National University of Singapore Medical School, Singapore, Singapore. .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Male SARS-CoV-2 variants

• Source: Scientific reports [Sci Rep] 2023 Oct 13; Vol. 13 (1), pp. 17337. Date of Electronic Publication: 2023 Oct 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CL Pro ) activity in silico and in vitro.

• Authors : Dakpa G; Molecular and Biological Agricultural Sciences Program, Taiwan International Graduate Program, Academia Sinica, Taipei, 108, Taiwan.; Graduate Institute of Biotechnology, National Chung Hsing University, Taichung, 402, Taiwan.

Subjects: COVID-19* ; Vaccines*; Humans Taiwanofungus camphoratus

• Source: Scientific reports [Sci Rep] 2023 Oct 10; Vol. 13 (1), pp. 17106. Date of Electronic Publication: 2023 Oct 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Conspiratorial thinking as a precursor to opposition to COVID-19 vaccination in the US: a multi-year study from 2018 to 2021.

• Authors : Romer D; Annenberg Public Policy Center, University of Pennsylvania, 202 S. 36th ST, Philadelphia, PA, 19104, USA. .; Jamieson KH

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2022 Nov 03; Vol. 12 (1), pp. 18632. Date of Electronic Publication: 2022 Nov 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.

• Authors : Homma T; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.; Nagata N

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Mice

• Source: Scientific reports [Sci Rep] 2022 Dec 02; Vol. 12 (1), pp. 20861. Date of Electronic Publication: 2022 Dec 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Risk-benefit analysis of emergency vaccine use.

• Authors : Lewis, Gregory; Bonsall, Michael

Subjects: RISK assessment; VACCINE effectiveness; VACCINE safety

• Source: Scientific Reports; 5/6/2022, Vol. 12 Issue 1, p1-8, 8p

Record details

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.

• Authors : Kuo, Tsun-Yung^1,2; Lin, Meei-Yun¹; Coffman, Robert L.³

• Source: Scientific Reports. 11/18/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.

Record details

Web and social media searches highlight menstrual irregularities as a global concern in COVID-19 vaccinations.

• Authors : Katz A; Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. .; Tepper Y

Subjects: Social Media* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: Scientific reports [Sci Rep] 2022 Oct 21; Vol. 12 (1), pp. 17657. Date of Electronic Publication: 2022 Oct 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

High rates of COVID-19 vaccine refusal among Afghan pregnant women: a cross sectional study.

• Authors : Nemat A; Department of Microbiology, Kabul University of Medical Sciences, 3rd District, Kabul, 1001, Afghanistan. .; Department of Cardiology, Ariana Medical Complex, Kabul, Afghanistan. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2022 Aug 18; Vol. 12 (1), pp. 14057. Date of Electronic Publication: 2022 Aug 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Understanding hesitancy with revealed preferences across COVID-19 vaccine types.

• Authors : Kutasi K; Department of Economics, Rice University, Houston, TX, 77005-1827, USA.; Koltai J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Urogenital Abnormalities*

• Source: Scientific reports [Sci Rep] 2022 Aug 02; Vol. 12 (1), pp. 13293. Date of Electronic Publication: 2022 Aug 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Cable news and COVID-19 vaccine uptake.

• Authors : Pinna M; Center for Law and Economics, ETH Zürich, Zurich, Switzerland. .; Picard L

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; COVID-19 Vaccines

• Source: Scientific reports [Sci Rep] 2022 Oct 07; Vol. 12 (1), pp. 16804. Date of Electronic Publication: 2022 Oct 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Measuring concerns about the COVID-19 vaccine among Japanese internet users through search queries.

• Authors : Uehara M; Nara Institute of Science and Technology (NAIST), Nara, Japan.; Fujita S

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Aged

• Source: Scientific reports [Sci Rep] 2022 Sep 03; Vol. 12 (1), pp. 15037. Date of Electronic Publication: 2022 Sep 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Misinformation of COVID-19 vaccines and vaccine hesitancy.

• Authors : Lee SK; School of Media and Communication, Korea University, 145 Anam-Ro, Seongbuk-Gu, Seoul, 02841, South Korea. .; Sun J

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; COVID-19 Vaccines

• Source: Scientific reports [Sci Rep] 2022 Aug 11; Vol. 12 (1), pp. 13681. Date of Electronic Publication: 2022 Aug 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Trusting COVID-19 vaccines as individual and social goal.

• Authors : Falcone R; Trust Theory and Technology Group, Institute of Cognitive Sciences and Technologies, National Research Council of Italy, Rome, Italy. .; Goal-Oriented Agents Lab, Institute of Cognitive Sciences and Technologies, National Research Council of Italy, Rome, Italy. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Scientific reports [Sci Rep] 2022 Jun 08; Vol. 12 (1), pp. 9470. Date of Electronic Publication: 2022 Jun 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details